Medicalsystem Biotechnology Co (SZSE:300439) ROCE % : 12.25% (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Medicalsystem Biotechnology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Medicalsystem Biotechnology Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 12.25%.

Medicalsystem Biotechnology Co ROCE % Historical Data

The historical data trend for Medicalsystem Biotechnology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicalsystem Biotechnology Co ROCE % Chart

Medicalsystem Biotechnology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-21.40

22.30

11.17

9.31

11.36

Medicalsystem Biotechnology Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															11.86	17.62	10.54	5.54	12.25

Medicalsystem Biotechnology Co ROCE % Calculation

Medicalsystem Biotechnology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	306.343	/	( ( (3583.676 - 981.304)	+	(3489.186 - 699.129) )	/ 2 )
	=	306.343	/	( (2602.372	+	2790.057)	/ 2 )
	=	306.343	/	2696.2145
	=	11.36 %

Medicalsystem Biotechnology Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	346.3	/	( ( (3489.186 - 699.129)	+	(3440.2 - 576.552) )	/ 2 )
	=	346.3	/	( ( 2790.057	+	2863.648 )	/ 2 )
	=	346.3	/	2826.8525
	=	12.25 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Medicalsystem Biotechnology Co (SZSE:300439) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Medicalsystem Biotechnology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Medicalsystem Biotechnology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicalsystem Biotechnology Co (SZSE:300439) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medicalsystem Biotechnology Co Ltd (SZSE:300439) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 299 Qiming South Road, Yinzhou District, Zhejiang Province, Ningbo City, CHN, 315104

Website

http://www.nbmedicalsystem.com

Medicalsystem Biotechnology Co Ltd is engaged in research and development, manufacture and distribution of diagnostic products. It provides in-vitro biochemical diagnostic reagents to healthcare facilities.

Executives

Zou Bing De	Director
Xiong Hui Ping	Secretary Dong
Zhuo Hong Ye	Director
Wu Li Shan	Supervisors
Fang Liang	Executives
Zou Ji Hua	Directors, executives
Wo Yan Bo	Executives

Medicalsystem Biotechnology Co (SZSE:300439) Headlines

No Headlines